KemPharm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, options, and ETFs commission-free!About KMPH
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy.
CEONeil F. McFarlane
CEONeil F. McFarlane
Employees69
Employees69
HeadquartersCelebration, Florida
HeadquartersCelebration, Florida
Founded2006
Founded2006
Employees69
Employees69
KMPH Key Statistics
Market cap247.13M
Market cap247.13M
Price-Earnings ratio-3.82
Price-Earnings ratio-3.82
Dividend yield—
Dividend yield—
Average volume183.38K
Average volume183.38K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.28
52 Week high$7.28
52 Week low$3.89
52 Week low$3.89